skip to Main Content

PEGPH20: Future Directions in Pancreatic Adenocarcinoma

PEGPH20: Future Directions in Pancreatic Adenocarcinoma
Andrew Ko, MD, provides his perspective on PEGPH20 given the phase III HALO-301 trial and potential drug combinations in the setting of pancreatic adenocarcinoma.
  Watch video here . . .


Back To Top